Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.

Lysophosphatidic acid (LPA) has been found to mediate myeloid differentiation, stimulate osteogenesis, alter cell proliferation and migration, and inhibit apoptosis in chondrocytes. The effect of LPA on the angiogenic capability of chondrocytes is not clear. This study aimed to investigate its effec...

Full description

Bibliographic Details
Main Authors: Yi-Wen Chuang, Wen-Ming Chang, Kai-Hua Chen, Chang-Zern Hong, Pey-Jium Chang, Hung-Chih Hsu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4039431?pdf=render
_version_ 1818694288315252736
author Yi-Wen Chuang
Wen-Ming Chang
Kai-Hua Chen
Chang-Zern Hong
Pey-Jium Chang
Hung-Chih Hsu
author_facet Yi-Wen Chuang
Wen-Ming Chang
Kai-Hua Chen
Chang-Zern Hong
Pey-Jium Chang
Hung-Chih Hsu
author_sort Yi-Wen Chuang
collection DOAJ
description Lysophosphatidic acid (LPA) has been found to mediate myeloid differentiation, stimulate osteogenesis, alter cell proliferation and migration, and inhibit apoptosis in chondrocytes. The effect of LPA on the angiogenic capability of chondrocytes is not clear. This study aimed to investigate its effect on the angiogenic capability of human chondrocytes and the underlying mechanism of these effects. Human chondrocyte cell line, CHON-001, commercialized human chondrocytes (HC) derived from normal human articular cartilage, and human vascular endothelial cells (HUVECs) were used as cell models in this study. The angiogenic capability of chondrocytes was determined by capillary tube formation, monolayer permeability, cell migration, and cell proliferation. An angiogenesis protein array kit was used to evaluate the secretion of angiogenic factors in conditioned medium. Angiogenin, insulin-like growth factor-binding protein 1 (IGFBP-1), interleukin (IL)-8, monocyte chemoattractant protein-1 (MCP-1), matrix metalloproteinase (MMP)-9, and vascular endothelial growth factor (VEGF) mRNA and protein expressions were evaluated by Q-RT-PCR and EIA, respectively. LPA receptor (LPAR) expression was determined by RT-PCR. Signaling pathways were clarified using inhibitors, Western blot analysis, and reporter assays. The LPA treatment promoted the angiogenic capability of CHON-001 cells and HC, resulting in enhanced HUVEC capillary tube formation, monolayer permeability, migration, and cell growth. Angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF mRNA and protein expressions were significantly enhanced in LPA-treated chondrocytes. LPA2, 3, 4 and 6 were expressed in CHON-001 and HC cells. Pretreatment with the Gi/o type G protein inhibitor, pertussis toxin (PTX), and the NF-kB inhibitor, PDTC, significantly inhibited LPA-induced angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF expressions in chondrocytes. The PTX pretreatment also inhibited LPA-mediated NF-kB activation, suggesting the presence of active Gi/NF-kB signaling in CHON-001 and HC cells. The effect of LPA on the angiogenesis-inducing capacity of chondrocytes may be due to the increased angiogenesis factor expression via the Gi/NF-kB signaling pathway.
first_indexed 2024-12-17T13:27:12Z
format Article
id doaj.art-b359bdc3a69948b384953b3e98194d55
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T13:27:12Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b359bdc3a69948b384953b3e98194d552022-12-21T21:46:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9518010.1371/journal.pone.0095180Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.Yi-Wen ChuangWen-Ming ChangKai-Hua ChenChang-Zern HongPey-Jium ChangHung-Chih HsuLysophosphatidic acid (LPA) has been found to mediate myeloid differentiation, stimulate osteogenesis, alter cell proliferation and migration, and inhibit apoptosis in chondrocytes. The effect of LPA on the angiogenic capability of chondrocytes is not clear. This study aimed to investigate its effect on the angiogenic capability of human chondrocytes and the underlying mechanism of these effects. Human chondrocyte cell line, CHON-001, commercialized human chondrocytes (HC) derived from normal human articular cartilage, and human vascular endothelial cells (HUVECs) were used as cell models in this study. The angiogenic capability of chondrocytes was determined by capillary tube formation, monolayer permeability, cell migration, and cell proliferation. An angiogenesis protein array kit was used to evaluate the secretion of angiogenic factors in conditioned medium. Angiogenin, insulin-like growth factor-binding protein 1 (IGFBP-1), interleukin (IL)-8, monocyte chemoattractant protein-1 (MCP-1), matrix metalloproteinase (MMP)-9, and vascular endothelial growth factor (VEGF) mRNA and protein expressions were evaluated by Q-RT-PCR and EIA, respectively. LPA receptor (LPAR) expression was determined by RT-PCR. Signaling pathways were clarified using inhibitors, Western blot analysis, and reporter assays. The LPA treatment promoted the angiogenic capability of CHON-001 cells and HC, resulting in enhanced HUVEC capillary tube formation, monolayer permeability, migration, and cell growth. Angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF mRNA and protein expressions were significantly enhanced in LPA-treated chondrocytes. LPA2, 3, 4 and 6 were expressed in CHON-001 and HC cells. Pretreatment with the Gi/o type G protein inhibitor, pertussis toxin (PTX), and the NF-kB inhibitor, PDTC, significantly inhibited LPA-induced angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF expressions in chondrocytes. The PTX pretreatment also inhibited LPA-mediated NF-kB activation, suggesting the presence of active Gi/NF-kB signaling in CHON-001 and HC cells. The effect of LPA on the angiogenesis-inducing capacity of chondrocytes may be due to the increased angiogenesis factor expression via the Gi/NF-kB signaling pathway.http://europepmc.org/articles/PMC4039431?pdf=render
spellingShingle Yi-Wen Chuang
Wen-Ming Chang
Kai-Hua Chen
Chang-Zern Hong
Pey-Jium Chang
Hung-Chih Hsu
Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
PLoS ONE
title Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
title_full Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
title_fullStr Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
title_full_unstemmed Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
title_short Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.
title_sort lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating gi nf kb dependent angiogenic factor expression
url http://europepmc.org/articles/PMC4039431?pdf=render
work_keys_str_mv AT yiwenchuang lysophosphatidicacidenhancedtheangiogeniccapabilityofhumanchondrocytesbyregulatingginfkbdependentangiogenicfactorexpression
AT wenmingchang lysophosphatidicacidenhancedtheangiogeniccapabilityofhumanchondrocytesbyregulatingginfkbdependentangiogenicfactorexpression
AT kaihuachen lysophosphatidicacidenhancedtheangiogeniccapabilityofhumanchondrocytesbyregulatingginfkbdependentangiogenicfactorexpression
AT changzernhong lysophosphatidicacidenhancedtheangiogeniccapabilityofhumanchondrocytesbyregulatingginfkbdependentangiogenicfactorexpression
AT peyjiumchang lysophosphatidicacidenhancedtheangiogeniccapabilityofhumanchondrocytesbyregulatingginfkbdependentangiogenicfactorexpression
AT hungchihhsu lysophosphatidicacidenhancedtheangiogeniccapabilityofhumanchondrocytesbyregulatingginfkbdependentangiogenicfactorexpression